MENU
+Compare
AXSM
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$107.89
Change
-$1.86 (-1.69%)
Capitalization
5.26B

AXSM Axsome Therapeutics Forecast, Technical & Fundamental Analysis

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AXSM with price predictions
Apr 02, 2025

AXSM's RSI Indicator stays in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXSM advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

AXSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AXSM as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AXSM turned negative on February 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

AXSM moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AXSM crossed bearishly below the 50-day moving average on April 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AXSM entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (93.458) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (13.643) is also within normal values, averaging (252.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AXSM is expected to report earnings to fall 16.23% to -128 cents per share on May 12

Axsome Therapeutics AXSM Stock Earnings Reports
Q1'25
Est.
$-1.29
Q4'24
Missed
by $0.58
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.36
Q1'24
Missed
by $0.22
The last earnings report on February 18 showed earnings per share of -153 cents, missing the estimate of -95 cents. With 754.31K shares outstanding, the current market capitalization sits at 5.26B.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services for pain and other nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CEW17.660.09
+0.54%
WisdomTree Emerging Currency Strat ETF
BSL14.05-0.07
-0.50%
Blackstone Senior Floating Rate 2027 Term Fund
NUGT61.26-0.34
-0.55%
Direxion Daily Gold Miners Bull 2X ETF
EWC40.62-0.97
-2.33%
iShares MSCI Canada ETF
FGB4.16-0.12
-2.80%
First Trust Specialty Finance and Financial Opportunities Fund

AXSM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with VANI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
-1.69%
VANI - AXSM
36%
Loosely correlated
-1.98%
PLRX - AXSM
35%
Loosely correlated
-6.74%
SWTX - AXSM
34%
Loosely correlated
-7.35%
CRNX - AXSM
34%
Loosely correlated
-8.03%
ACHV - AXSM
34%
Loosely correlated
-5.10%
More